文化大學機構典藏 CCUR:Item 987654321/30601
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46962/50828 (92%)
Visitors : 12441464      Online Users : 777
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/30601


    Title: Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[F-18]-fluorothymidine PET
    Authors: Chan, Pei-Chia
    Wu, Chun-Yi
    Chou, Lin-Shan
    Ho, Chung-Hsien
    Chang, Chi-Wei
    Chiou, Shih-Hwa
    Lin, Wuu-Jyh
    Chen, Fu-Du
    Chang, C.Allen
    Hwang, Jeng-Jong
    Liu, Ren-Shyan
    Wang, Hsin-Ell
    Contributors: Grad Inst Biotechnol
    Keywords: [F-18]FLT
    HDACi
    Treatment response
    MicroPET
    Hepatocellular carcinoma
    Date: 2015-06
    Issue Date: 2015-10-23 13:37:43 (UTC+8)
    Abstract: This study employed 3'-deoxy-3'-[F-18]-fluorothymidine ([F-18]FLT) microPET scanning to assess the treatment response of histone deacetylase inhibitors (HDACi), e.g., N1-hydroxy-N8-phenyloctanediamide (SAHA) and its iodinated derivative ISAHA, in a hepatoma mouse model.

    The in vitro cytotoxicity of HDACi in various hepatoma cell lines was determined by MTT assay and flow cytometry. ISAHA and SAHA were used to treat HepG2 hepatoma xenograft-bearing mice. The treatment responses were characterized in terms of tumor burden, microPET imaging, and immunohistochemical staining of tumor sections.

    ISAHA effectively inhibited HepG2 hepatoma cell survival and tumor growth. A significantly reduced tumor uptake during HDACi treatment was noticed in [F-18]FLT microPET imaging, which was consistent with the findings in immunohistochemical staining.

    ISAHA can suppress tumor cell proliferation both in vitro and in vivo. [F-18]FLT PET is a promising modality for evaluating the in vivo therapeutic efficacy of HDACi at the early stage of treatment.
    Relation: MOLECULAR IMAGING AND BIOLOGY 卷: 17 期: 3 頁碼: 394-402
    Appears in Collections:[Graduate Institute of Biotechnology ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML340View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback